Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Seagen Inc.
Janssen Research & Development, LLC
AstraZeneca
AstraZeneca
Pfizer
Tesaro, Inc.
Merck Sharp & Dohme LLC
Novartis
Hoffmann-La Roche
BeOne Medicines
Ipsen
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
AstraZeneca
Novartis
Pfizer
AstraZeneca
AstraZeneca
Gamida Cell ltd
Janssen Research & Development, LLC
Seagen Inc.
Eisai Inc.
Regeneron Pharmaceuticals
Merck Sharp & Dohme LLC
Novartis
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Acerta Pharma BV
AstraZeneca
Bristol-Myers Squibb
AstraZeneca
Astellas Pharma Inc
Janssen Research & Development, LLC
European Myeloma Network B.V.
Gustave Roussy, Cancer Campus, Grand Paris
Sanofi
Acerta Pharma BV
Hoffmann-La Roche
Astellas Pharma Inc
Amgen
Daiichi Sankyo
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC